This suppression of BCR-ABL not only impaired leukemic cell survival but also enhanced apoptotic signaling, highlighting the extract’s potential to target the oncogenic driver of CML [80]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.